1. Home
  2. PMCB vs YMAT Comparison

PMCB vs YMAT Comparison

Compare PMCB & YMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.49

Market Cap

6.3M

Sector

Health Care

ML Signal

HOLD

Logo J-Star Holding Co. Ltd. Ordinary Shares

YMAT

J-Star Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$1.69

Market Cap

7.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMCB
YMAT
Founded
1996
1970
Country
United States
Taiwan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
7.3M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
PMCB
YMAT
Price
$0.49
$1.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
84.1K
13.2K
Earning Date
03-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$10.92
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$0.24
52 Week High
$1.51
$2.94

Technical Indicators

Market Signals
Indicator
PMCB
YMAT
Relative Strength Index (RSI) 31.46 50.70
Support Level N/A $0.33
Resistance Level $0.57 $1.99
Average True Range (ATR) 0.03 0.15
MACD -0.00 -0.02
Stochastic Oscillator 20.99 47.72

Price Performance

Historical Comparison
PMCB
YMAT

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a biotechnology company focused on developing cellular therapies for cancer based on its proprietary cellulose-based live cell encapsulation technology, Cell-in-a-Box. The technology is intended to be used as a platform for therapies for several types of cancer, including locally advanced, inoperable pancreatic cancer (LAPC). The current generation of the Company's product candidate is CypCaps. The Company is preparing to commercialize cellular therapies for cancer and advance clinical research and development, including a clinical trial in LAPC using encapsulated live cells. Its candidate therapy involves encapsulating genetically engineered human cells that convert an inactive chemotherapy drug into its active, cancer-killing form.

About YMAT J-Star Holding Co. Ltd. Ordinary Shares

J-Star Holding Co Ltd is engaged in the research, development, and manufacturing of carbon fiber for a wide variety-of-products including carbon bicycles, carbon rackets, automotive parts, outdoor sports gears, and healthcare products. The company has five segments: Bicycle frame, Racket, Crank, Service provision, and Others. The majority of its revenue is generated from the Bicycle frame segment. Geographically, the company operates in Taiwan, China, and other regions.

Share on Social Networks: